Blue Bell Private Wealth Management’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36 | Hold |
10
| – | – | ﹤0.01% | 726 |
|
|
2025
Q1 | $22 | Hold |
10
| – | – | ﹤0.01% | 717 |
|
|
2024
Q4 | $31 | Hold |
10
| – | – | ﹤0.01% | 673 |
|
|
2024
Q3 | $23 | Hold |
10
| – | – | ﹤0.01% | 685 |
|
|
2024
Q2 | $28 | Hold |
10
| – | – | ﹤0.01% | 713 |
|
|
2024
Q1 | $44 | Hold |
10
| – | – | ﹤0.01% | 720 |
|
|
2023
Q4 | $77 | Hold |
10
| – | – | ﹤0.01% | 713 |
|
|
2023
Q3 | $72 | Hold |
10
| – | – | ﹤0.01% | 672 |
|
|
2023
Q2 | $94 | Hold |
10
| – | – | ﹤0.01% | 678 |
|
|
2023
Q1 | $165 | Hold |
10
| – | – | ﹤0.01% | 654 |
|
|
2022
Q4 | $266 | Hold |
10
| – | – | ﹤0.01% | 680 |
|
|
2022
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 669 |
|
|
2022
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 716 |
|
|
2022
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 781 |
|
|
2021
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 772 |
|